Study guide
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit
Utah MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC
1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline
2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel
2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel
3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment
3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement
4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing
4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records
5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards
6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration
6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting
7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs
7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program
8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah
8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security
9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)
10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products
10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales
11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery
11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients
12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs
12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards
13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation
13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit
Key Takeaways Explain This Topic AI
A Utah Schedule II prescription may not be refilled and may not be filled for more than a one-month supply based on the prescribed daily dose (Utah Code § 58-37-304(6)(b)–(c)).
A Utah Schedule II prescription may not be dispensed if it is presented more than 30 days after issuance, or 30 days after a separately written dispensing date (Utah Code § 58-37-304(6)(g)).
A Utah prescriber may issue up to three Schedule II prescriptions for the same drug at once, each for no more than 30 days, with the second and third showing both the issue date and the dispensing date.
Under R156-37-603(3), the dispensing date on a second or third Schedule II prescription must be at least 30 days after the previous dispensing date unless the prescriber documents a valid medical reason.
A CII or CIII opiate prescribed for an acute condition is limited to a 7-day supply unless the medical record documents a complex or chronic condition, and the pharmacist need not verify compliance (Utah Code § 58-37-304(6)(d)).
Last updated: September 2026
9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit
Blueprint item 2.1 covers "requirements for issuing controlled prescriptions" and "authority limitations of practitioners' ability to authorize refills." Since July 1, 2026 , Utah's Schedule II rules are in § 58-37-304(6) (formerly § 58-37-6(7)(f)), supplemented by R156-37-603 .
The core Utah Schedule II rules
These rules apply except when a licensed practitioner administers a controlled substance directly to an ultimate user (§ 58-37-304(6)(a)):
Rule Utah law Federal comparison
No refills A Schedule II prescription may not be refilled (§ 58-37-304(6)(b); R156-37-603(4)(b)) Same (21 CFR 1306.12(a))
Quantity No more than a one-month supply , based on the prescribed daily dose (§ 58-37-304(6)(c)) No federal day-supply cap
Presentation window May not be dispensed if not presented to a pharmacist or intern within 30 days after the issue date , or 30 days after a separately written dispensing date (§ 58-37-304(6)(g)) No federal expiration
Multiple prescriptions Up to three prescriptions for the same CII drug at once; none over 30 days ; the second and third must show both the issue date and the dispensing date (§ 58-37-304(6)(h)) Up to a 90-day total with "earliest fill" dates, where state law permits (21 CFR 1306.12(b))
Spacing Dispensing date of the 2nd and 3rd prescriptions must be at least 30 days after the previous dispensing date , unless the prescriber finds a valid medical reason for an earlier date (R156-37-603(3)) Prescriber sets earliest fill dates
Acute opiates A CII or CIII opiate for an acute condition must be completely or partially filled for no more than a 7-day supply , unless the medical record documents a complex or chronic condition. The pharmacist is not required to verify compliance. (§ 58-37-304(6)(d)) No federal limit
How the 30-day window works with multiple prescriptions
Suppose a prescriber writes three methylphenidate prescriptions on March 1. The second says "Do not dispense before March 31," and the third says "Do not dispense before April 30."
Prescription 1 must be presented by March 31 (30 days after issue).
Prescription 2 may be dispensed on or after March 31 and must be presented by April 30 (30 days after its dispensing date).
Prescription 3 may be dispensed on or after April 30 and must be presented by May 30 .
Utah's 30-day window runs from the dispensing date when one is written separately. Federal rules separately forbid post-dating : each prescription must bear the actual date it was signed.
Required contents and signatures (§ 58-37-304(4))
A Schedule II prescription must include the prescriber's name, address, and DEA number; the patient's name, address, and age ; the date of issuance; and the drug name, quantity, and specific directions . It must be signed in ink, indelible pencil, or with an authorized electronic signature. In Utah it must be electronic unless an EPCS exemption applies (Section 4.3). DOPL's July 2024 clarification lists what a pharmacist may add or change after consulting the prescriber (Section 4.2).
Hospital orders (§ 58-37-304(7))
A controlled substance order for a hospital inpatient or outpatient is exempt from these requirements if:
it is issued by a prescriber with an unrestricted DEA registration and an active Utah controlled substance license (or an exempt resident);
the treating prescriber designates the quantity;
it is entered in the patient's record, with the prescriber signing to affirm the order within 48 hours of filling or administering; and
it is filled by a pharmacist within the hospital, or taken from hospital supply and administered directly to the patient.
Prescriber duties tied to Schedule II opioids
CSD check: before the first Schedule II or III opioid prescription to a patient, and periodically during repeated prescribing (§ 58-37f-304(2); Section 9.4).
High-risk prescriptions: an opiate or benzodiazepine written to continue longer than 30 consecutive days requires checking the CSD for another active high-risk prescription from a different practitioner, and if one exists, consulting that practitioner and documenting the reason (§ 58-37-305).
Initial opiate prescription: discuss the risks and offer an opiate antagonist at 50 MME/day or more or with a benzodiazepine (§ 58-37-306; Section 7.1).
Minors: consent of a parent or guardian is required except in an emergency (§ 58-37-304(8)).
Scenarios
Day 33. A paper-exempt oxycodone prescription dated June 1 is presented July 4. It may not be dispensed, because it is more than 30 days after issuance. The patient needs a new prescription.
45-day quantity. A prescription for hydromorphone written for a 45-day supply exceeds the one-month limit. Contact the prescriber, and consider a partial fill (Section 9.2) or a new prescription.
Post-surgical oxycodone for 10 days. This exceeds the 7-day acute limit unless the prescriber documented a complex or chronic condition. The pharmacist is not required to verify compliance, but may use professional judgment and contact the prescriber.